{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:51:50Z","timestamp":1786985510002,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.breast.2016.10.018","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T11:31:42Z","timestamp":1477567902000},"page":"16-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors"],"prefix":"10.1016","volume":"31","author":[{"given":"Lidija","family":"Bo\u0161kovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Ga\u0161pari\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Petkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damir","family":"Gugi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid Belac","family":"Lovasi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017deljko","family":"Soldi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka Petri\u0107","family":"Mi\u0161e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Dabeli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljubica","family":"Vazdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vrdoljak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2016.10.018_bib1","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/cncr.21335","article-title":"Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer","volume":"104","author":"Chen","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2016.10.018_bib2","first-page":"2089","article-title":"In\u00a0vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients","volume":"4","author":"Geisler","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.breast.2016.10.018_bib3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.2002.20.3.751","article-title":"Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study","volume":"20","author":"Geisler","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"4\u20135","key":"10.1016\/j.breast.2016.10.018_bib4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jsbmb.2009.10.004","article-title":"Impact of aromatase inhibitors on bone health in breast cancer patients","volume":"118","author":"Geisler","year":"2010","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.breast.2016.10.018_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.critrevonc.2008.07.013","article-title":"Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis","volume":"69","author":"Hadji","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10.1016\/j.breast.2016.10.018_bib6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","article-title":"Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98","volume":"25","author":"Coates","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2016.10.018_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1470-2045(07)70003-7","article-title":"Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomized controlled study","volume":"8","author":"Coleman","year":"2007","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.breast.2016.10.018_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial","volume":"9","author":"Arimidex","year":"2008","journal-title":"Lancet Oncol"},{"issue":"9484","key":"10.1016\/j.breast.2016.10.018_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(05)67059-6","article-title":"Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial","volume":"366","author":"Jakesz","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2016.10.018_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.6004\/jnccn.2009.0076","article-title":"NCCN task force report: bone health in Cancer care","volume":"7","author":"Gralow","year":"2009","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"23","key":"10.1016\/j.breast.2016.10.018_bib11","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","article-title":"Vitamin D3 and calcium to prevent hip fractures in the elderly women","volume":"327","author":"Chapuy","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.breast.2016.10.018_bib12","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1056\/NEJM199709043371003","article-title":"Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older","volume":"337","author":"Dawson-Hughes","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.breast.2016.10.018_bib13","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1210\/jc.2011-1193","article-title":"Clinical review: the effect of vitamin D on falls: a systematic review and meta-analysis","volume":"96","author":"Murad","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.breast.2016.10.018_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/annonc\/mdu103","article-title":"ESMO guidelines working Group. Bone health in cancer patients: ESMO clinical practice guidelines","volume":"3","author":"Coleman","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2016.10.018_bib15","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.2003.08.017","article-title":"American Society of Clinical Oncology 2003 update on the role of bisphosphonate and bone health issues in women with breast cancer","volume":"21","author":"Hillner","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.breast.2016.10.018_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","article-title":"American Cancer society\/American society of clinical oncology breast Cancer survivorship care guideline","volume":"34","author":"Runowicz","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2016.10.018_bib17","unstructured":"Vrdoljak E, Boskovic L, Gasparic M, Belac Lovasic I, Soldic Z, Petric Mise B, et\u00a0al. Adherence to aromatase inhibitors, vitamin D and calcium in breast cancer patients in Croatia (abstract). In: 12th Central European Oncology Congress; 2016 June 22-25; Opatija, Croatia. Abstr.nr 2."},{"key":"10.1016\/j.breast.2016.10.018_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrrheum.2013.36","article-title":"Management of cancer treatment-induced bone loss","volume":"9","author":"Coleman","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.breast.2016.10.018_bib19","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.bjc.6690188","article-title":"A\u00a0high incidence of vertebral fracture in women with breast cancer","volume":"79","author":"Kanis","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2016.10.018_bib20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archinte.165.5.552","article-title":"Fracture risk among breast cancer survivors: results from the Women's Health Initiative observational study","volume":"165","author":"Chen","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.breast.2016.10.018_bib21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1634\/theoncologist.11-10-1121","article-title":"Bone loss and fracture risk associated with cancer therapy","volume":"11","author":"Guise","year":"2006","journal-title":"Oncol"},{"key":"10.1016\/j.breast.2016.10.018_bib22","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1210\/jcem.84.6.5710","article-title":"Bone densitometry: the best way to detect osteoporosis and to monitor therapy","volume":"84","author":"Miller","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.breast.2016.10.018_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)61342-7","article-title":"Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis","volume":"370","author":"Tang","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.breast.2016.10.018_bib24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2147\/TCRM.S3552","article-title":"The use of calcium and vitamin D in the management of osteoporosis","volume":"4","author":"Sunyecz","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.breast.2016.10.018_bib25","first-page":"CD000227","article-title":"Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men","volume":"4","author":"Avenell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.breast.2016.10.018_bib26","first-page":"295","article-title":"The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause","volume":"4","author":"Tham","year":"2006","journal-title":"J\u00a0Support Oncol"},{"issue":"6","key":"10.1016\/j.breast.2016.10.018_bib27","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3109\/13697130903452804","article-title":"UNICAD study investigators. Treatment persistence and compliance with a combination of calcium and vitamin D","volume":"13","author":"Castelo-Branco","year":"2010","journal-title":"Climacteric"},{"issue":"10","key":"10.1016\/j.breast.2016.10.018_bib28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/11317070-000000000-00000","article-title":"Determinant factors of osteoporosis patients' reported therapeutic adherence to calcium and\/or vitamin D supplements: a cross-sectional, observational study of postmenopausal women","volume":"26","author":"Sanfelix-Genov\u00e9s","year":"2009","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.breast.2016.10.018_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/gme.0b013e318223bd6b","article-title":"Observational study of treatment compliance in women initiating antiresorptive therapy with or without calcium and vitamin D supplements in Spain","volume":"19","author":"D\u00edez","year":"2012","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.breast.2016.10.018_bib30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/jwh.2012.3687","article-title":"Bone mineral density screening among women with a history of breast cancer treated with aromatase inhibitors","volume":"22","author":"Spangler","year":"2013","journal-title":"J\u00a0Womens Health (Larchmt)"},{"issue":"9","key":"10.1016\/j.breast.2016.10.018_bib31","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1176\/ps.2007.58.9.1187","article-title":"Relationships among subjective and objective measures of adherence to oral antipsychotic medications","volume":"58","author":"Velligan","year":"2007","journal-title":"Psychiatr Serv"},{"issue":"2","key":"10.1016\/j.breast.2016.10.018_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1345\/aph.1D252","article-title":"Measurement, correlates, and health outcomes of medication adherence among seniors","volume":"38","author":"Vik","year":"2004","journal-title":"Ann Pharmacother"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977616302004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977616302004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:35:18Z","timestamp":1760776518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977616302004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":32,"alternative-id":["S0960977616302004"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2016.10.018","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2016.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}